Patricia Chu, MD

Endocrinology
Independent provider
Accepting new patients
Sees patients age 18 and up
Penn Rodebaugh Diabetes Center
Schedule onlineCall 215-662-2468

About me

  • Instructor A of Pediatrics

My education and training

  • Medical School: Duke University Medical Center
  • Residency: Vanderbilt University
  • Fellowship: University of Pennsylvania Health System
  • Fellowship: Children's Hospital of Philadelphia

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Chu is an independent physician who is not employed by Penn Medicine.

Qualifications and experience

Treatments and Conditions

Research

Publications

Chu PY, Kelly A, Hennessy S, Vajravelu ME, Huang J, Amaral S GLP-1RA Dispensing in Youth With Type 2 Diabetes: 2020 to 2023 , Pediatrics: 2026

Chu PY, Parimi N, Wolf RM, Brown EA, Kelly A, Marks BE Real-World Safety and Effectiveness of U200 Insulin Use in Automated Insulin Delivery Systems in Adolescents and Young Adults with Type 1 Diabetes , Diabetes Technol Ther: 2025

Marks BE, Chu PY, Parimi N, Wolf RM, Tran M, Berget C Practical considerations for using concentrated U200 insulin in automated insulin delivery systems , Frontiers in Endocrinology: 2025

Kelly A, Shirley Bezerra M, Fitzpatrick K, Adams K, Arputhan A, Walega R, Chu PY, Cockcroft J, Townsend RR. Modest Blood Pressure Increase with Age in Adults with Down's Syndrome , N Engl J Med, 392: 2025,1346-1348

Chu PY, Edmondson EK, Flory JH, Huang J, Hennessy S. Risk of Hypoglycemia Associated With Concomitant Use of Insulin Secretagogues and ACE Inhibitors in Adults With Type 2 Diabetes: A Systematic Review , Clin Pharmacol Ther: 2025

Vajravelu ME, Chu PY, Frank DA, Ragavan MI, Vajravelu RK. Projected impact of anti-obesity pharmacotherapy use on racial and ethnic disparities in adolescent obesity , Pediatr Obes: 2024

Chu P, Patel A, Helgeson V, Goldschmidt AB, Ray MK, Vajravelu ME. Perception and Awareness of Diabetes Risk and Reported Risk-Reducing Behaviors in Adolescents , JAMA Netw Open, 6: 2023,e2311466

Kazerouninia A, Georgekutty J, Kendsersky P, Byrne RD, Seto B, Chu PY, Wang Y, Rodriguez FH 3rd, Smith C, Saraf A, Lloyd MS, Frischhertz BP, Parekh DR, Ermis PR, Franklin WJ, Lam WW. A Multisite Retrospective Review of Direct Oral Anticoagulants Compared to Warfarin in Adult Fontan Patients , Cardiovasc Drugs Ther: 2023

Chu PY, Burks ML, Sólorzano CC, Bao S. ROBOTIC PARAGANGLIOMA RESECTION IN A PREGNANT PATIENT , AACE Clin Case Rep, 6: 2020,e197-e200

Chu PY, Hackstadt AJ, Chipman J, Griffin MR, Hung AM, Greevy RA Jr, Grijalva CG, Elasy T, Roumie CL. Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas , Diabetes Care: 2020